Jain Koo a,b, Yuseon Shin a,b, Hyewon Jeon a,b, Jaehyun Cheong a,b, Seongmin Cho c, Chanho Park c, Ee Chan Song c, Jacob D. Ramsey d, Chaemin Lim e,f, Kyung Taek Oh a,b
aDepartment of Global Innovative Drugs, The Graduate School of Chung-Ang University, 221 Heukseok-dong, Dongjak-gu, Seoul 06974, Republic of Korea
bCollege of Pharmacy, Chung-Ang University, 221 Heukseok-dong, Dongjak-gu, Seoul 06974, Republic of Korea
cRemedi Co., Ltd. Research center, Songdo 21990, Republic of Korea
dCenter for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
eCollege of Pharmacy, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea
fCHA Advanced Research Institute, CHA Bundang Medical Center, 335 Pangyo-ro, Bundang-gu, Seongnam-si, 13488 Gyeonggi-do, Republic of Korea
Corresponding authors: Chaemin Lim, Kyung Taek Oh